Drugs / P-TOLUENESULFONAMIDE
P-TOLUENESULFONAMIDE
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03448211 | May 2018 → May 2019 | neoplasm | PTS International Inc. | Withdrawn | No outcome recorded Stop: Business |
| Phase 21 trial | ||||||
| Phase 2 | NCT03447951 | Jun 2018 → Dec 2024 | hepatocellular carcinoma | Gongwin Biopharm Co., Ltd. | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03448146 | Aug 2009 → Dec 2011 | non-small cell lung carcinoma | PTS International Inc. | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-TOLUENESULFONAMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | NSC-9908 | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | P-methylbenzenesulfonamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | P-toluenesulfonylamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | P-tosylamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | Para-Toluenesulfonamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03448146 ↗ |
| Known as | Paratoulene sulfonamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Known as | PTS100 | “PTS100 (Para-Toluenesulfonamide): 30%TTV” NCT03447951 ↗ |
| Known as | Toluenesulfonamide, p- | ChEMBL registry synonym — accepted as the source's own label CHEMBL574 ↗ |
| Modality | Small molecule | — CHEMBL574 ↗ |
| Route | Other | “intratumoral PTS injection” NCT03448146 ↗ |